Assessing the risk of bias of quantitative analytical studies: introducing the vision for critical appraisal within JBI systematic reviews
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F23%3A00133379" target="_blank" >RIV/00216224:14110/23:00133379 - isvavai.cz</a>
Výsledek na webu
<a href="https://journals.lww.com/jbisrir/fulltext/2023/03000/assessing_the_risk_of_bias_of_quantitative.2.aspx" target="_blank" >https://journals.lww.com/jbisrir/fulltext/2023/03000/assessing_the_risk_of_bias_of_quantitative.2.aspx</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.11124/JBIES-22-00224" target="_blank" >10.11124/JBIES-22-00224</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Assessing the risk of bias of quantitative analytical studies: introducing the vision for critical appraisal within JBI systematic reviews
Popis výsledku v původním jazyce
A key step in the systematic review process is the assessment of the methodological quality (or risk of bias) of the included studies. At JBI, we have developed several tools to assist with this evaluation. As evidence synthesis methods continue to evolve, it has been necessary to revise and reflect on JBI's current approach to critical appraisal and to plan a strategy for the future. In this first paper of a series focusing on risk of bias assessment, we introduce our vision for risk of bias assessment for JBI. In future papers in this series, the methodological approach taken for this revision process will be discussed, along with the revised tools and guidance for using these tools.
Název v anglickém jazyce
Assessing the risk of bias of quantitative analytical studies: introducing the vision for critical appraisal within JBI systematic reviews
Popis výsledku anglicky
A key step in the systematic review process is the assessment of the methodological quality (or risk of bias) of the included studies. At JBI, we have developed several tools to assist with this evaluation. As evidence synthesis methods continue to evolve, it has been necessary to revise and reflect on JBI's current approach to critical appraisal and to plan a strategy for the future. In this first paper of a series focusing on risk of bias assessment, we introduce our vision for risk of bias assessment for JBI. In future papers in this series, the methodological approach taken for this revision process will be discussed, along with the revised tools and guidance for using these tools.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
30230 - Other clinical medicine subjects
Návaznosti výsledku
Projekt
<a href="/cs/project/LTC20031" target="_blank" >LTC20031: Towards an International Network for Evidence-based Research in Clinical Health Research in the Czech Republic</a><br>
Návaznosti
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Ostatní
Rok uplatnění
2023
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
JBI Evidence Synthesis
ISSN
2689-8381
e-ISSN
2689-8381
Svazek periodika
21
Číslo periodika v rámci svazku
3
Stát vydavatele periodika
US - Spojené státy americké
Počet stran výsledku
5
Strana od-do
467-471
Kód UT WoS článku
000945987900002
EID výsledku v databázi Scopus
2-s2.0-85150000476